LOGO
LOGO

Article Search

Discover the power of RTTNews website's advanced search page, designed for seamless Article retrieval by Company Name, Stock Symbol, and other criteria.
Stay updated with the Latest News on specific Companies, Financial Insights, and Market Trends. We Ensure you to get the most relevant information instantly.

Symbol  
Company  
Currency Symbol   eg (EUR/USD)
Keyword  
  • Lehman Brothers Reiterates Bristol-Myers Squibb Co. (BMY) At Overweight With $27 Price Target 7/25/2008 2:57:01 PM
  • Credit Suisse Is Increasing Bristol-Myers Squibb Co. (BMY) 2009 Estimate To 2.03 From 1.95 7/25/2008 10:19:33 AM
  • Credit Suisse Is Cutting Bristol-Myers Squibb Co. (BMY) 2009 Estimate To 1.95 From 1.96 7/11/2008 11:41:36 AM
  • Credit Suisse Is Cutting Bristol-Myers Squibb Co. (BMY) 2008 Estimate To 1.64 From 1.67 7/11/2008 11:36:34 AM
  • Bristol-Myers Squibb Co. (BMY) Declares 0.31 Dividend, Record Date 7/7/2008 6/10/2008 4:39:21 PM
  • Cowen & Co. Is Lowering Bristol-Myers Squibb Co. (BMY) 2009 Estimate To 1.75 From 1.85 6/4/2008 9:27:37 AM
  • Cowen & Co. Downgrades Bristol-Myers Squibb Co. (BMY) To Neutral From Outperform 6/4/2008 9:18:13 AM
  • Credit Suisse Is Cutting Bristol-Myers Squibb Co. (BMY) 2009 Estimate To 1.96 From 1.99 5/27/2008 9:59:28 AM
  • Credit Suisse Is Cutting Bristol-Myers Squibb Co. (BMY) 2008 Estimate To 1.67 From 1.70 5/27/2008 9:58:28 AM
  • Cowen & Co. Is Lowering Bristol-Myers Squibb Co. (BMY) 2009 Estimate To 1.85 From 1.95 5/21/2008 9:40:21 AM
  • Cowen & Co. Is Cutting Bristol-Myers Squibb Co. (BMY) 2008 Estimate To 1.60 From 1.70 5/21/2008 9:39:14 AM
  • Lehman Brothers Reiterates Bristol-Myers (BMY) At 5/2/2008 11:56:06 AM
  • Bristol-Myers Squibb (BMY) Has Lowered Its FY08 EPS Estimate To 1.60 - 1.70 From 1.65 - 1.75 1/31/2008 7:49:39 AM
  • Cowen & Co. Raises Bristol-Myers Squibb Co. (BMY) To Neutral From Underperform 11/19/2007 9:30:45 AM
Copyright © 2026 RTTNews. All rights reserved. By using this site, you agree to the Terms of Service. About Us   |   Contact Us   |   Privacy   |   Sitemap